Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Ulthera, Inc. — Predicate Candidate Screening

14 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

89 daysmedian FDA review time
171 days90th percentile
14clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K260618Ulthera® SystemUlthera, Inc.2026-05-21850
K250418Ulthera System (UC-1 Control Unit PRIME Model 2.1)Ulthera, Inc.2025-05-13890
K243035Ulthera® SystemUlthera, Inc.2025-02-241500
K233996Ulthera System (UC-1 Control Unit PRIME)Ulthera, Inc.2024-02-22660
K192185The Cellfina SystemUlthera, Inc.2019-10-09580
K180623Ulthera SystemUlthera, Inc.2018-05-04560
K161885The Cellfina SystemUlthera, Inc.2016-10-05861
K153677The Cellfina SystemUlthera, Inc.2016-02-25660
K150505Cellfina SystemUlthera, Inc.2015-07-291540
K134032ULTHERA SYSTEMUlthera, Inc.2014-06-201710
K132028ULTHERA SYSTEMUlthera, Inc.2013-12-111630
K121700ULTHERA SYSTEMUlthera, Inc.2012-10-021170
K122528ULTHERA SYSTEMUlthera, Inc.2012-08-2880
DEN080006ULTHERA SYSTEM, MODEL 8850-0001Ulthera, Inc.2009-09-115180

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda